Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 7 | 2018 | 585 | 1.060 |
Why?
|
| Brain Ischemia | 3 | 2018 | 146 | 1.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2014 | 30 | 0.930 |
Why?
|
| Registries | 1 | 2018 | 298 | 0.560 |
Why?
|
| Neurology | 3 | 2013 | 45 | 0.530 |
Why?
|
| Histoplasmosis | 1 | 2015 | 2 | 0.510 |
Why?
|
| Vasculitis | 1 | 2015 | 24 | 0.500 |
Why?
|
| Cerebrovascular Disorders | 1 | 2014 | 52 | 0.470 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 56 | 0.470 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 12 | 0.440 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2013 | 7 | 0.440 |
Why?
|
| Mentors | 1 | 2013 | 31 | 0.440 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 21 | 0.430 |
Why?
|
| Internship and Residency | 2 | 2013 | 313 | 0.340 |
Why?
|
| HIV Infections | 1 | 2014 | 394 | 0.340 |
Why?
|
| Epinephrine | 1 | 2005 | 40 | 0.250 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2005 | 42 | 0.250 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 68 | 0.250 |
Why?
|
| Aspirin | 2 | 2008 | 63 | 0.210 |
Why?
|
| Carotid Stenosis | 2 | 2002 | 58 | 0.200 |
Why?
|
| Ophthalmic Artery | 1 | 2002 | 9 | 0.200 |
Why?
|
| Humans | 15 | 2018 | 32005 | 0.190 |
Why?
|
| Male | 8 | 2018 | 19165 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2018 | 10 | 0.160 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 70 | 0.150 |
Why?
|
| Clinical Competence | 3 | 2005 | 333 | 0.150 |
Why?
|
| Coronary Disease | 1 | 2008 | 211 | 0.140 |
Why?
|
| Students, Medical | 3 | 2014 | 131 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3509 | 0.130 |
Why?
|
| Middle Aged | 6 | 2015 | 11817 | 0.120 |
Why?
|
| Aged | 6 | 2018 | 10301 | 0.120 |
Why?
|
| Multimedia | 2 | 2005 | 19 | 0.120 |
Why?
|
| Patient Simulation | 2 | 2005 | 32 | 0.120 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 517 | 0.120 |
Why?
|
| Information Storage and Retrieval | 1 | 2014 | 22 | 0.120 |
Why?
|
| Curriculum | 2 | 2014 | 213 | 0.120 |
Why?
|
| Female | 8 | 2018 | 19959 | 0.110 |
Why?
|
| Computer Simulation | 2 | 2005 | 220 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2014 | 126 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 3990 | 0.110 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 44 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2011 | 125 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 1328 | 0.090 |
Why?
|
| Brain | 2 | 2015 | 951 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3306 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2011 | 349 | 0.080 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 54 | 0.060 |
Why?
|
| Spinal Puncture | 1 | 2005 | 20 | 0.060 |
Why?
|
| Medical Staff, Hospital | 1 | 2005 | 20 | 0.060 |
Why?
|
| Thalamus | 1 | 2005 | 33 | 0.060 |
Why?
|
| Ticlopidine | 1 | 2004 | 17 | 0.060 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2005 | 86 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 48 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 83 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 5 | 0.060 |
Why?
|
| Obesity | 1 | 2011 | 1175 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2008 | 100 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1428 | 0.050 |
Why?
|
| Anterior Cerebral Artery | 1 | 2002 | 2 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2002 | 5 | 0.050 |
Why?
|
| Collateral Circulation | 1 | 2002 | 9 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 19 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2002 | 48 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 77 | 0.050 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 35 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2002 | 60 | 0.050 |
Why?
|
| Adult | 1 | 2014 | 9345 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 297 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 582 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 918 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 33 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 876 | 0.040 |
Why?
|
| Cause of Death | 1 | 2008 | 236 | 0.040 |
Why?
|
| Risk Factors | 2 | 2004 | 3876 | 0.040 |
Why?
|
| Florida | 2 | 2005 | 37 | 0.030 |
Why?
|
| Librarians | 1 | 2014 | 2 | 0.030 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 28 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 54 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 185 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2005 | 762 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 767 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 898 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2011 | 18 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2011 | 44 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 881 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 177 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 293 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2011 | 131 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 1497 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 198 | 0.020 |
Why?
|
| Diet | 1 | 2011 | 391 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2011 | 494 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 480 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 2149 | 0.020 |
Why?
|
| Exercise | 1 | 2011 | 672 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 23 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 263 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 288 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2003 | 73 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 525 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2003 | 123 | 0.010 |
Why?
|
| United States | 1 | 2011 | 3939 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 155 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 2282 | 0.010 |
Why?
|